Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A phosphate groups are the anionic moieties located at the 1 and 4' positions of the glucosamine disaccharide backbone of lipid A, which serves as the hydrophobic anchor of lipopolysaccharides (LPS) in Gram-negative bacteria (Raetz & Whitfield, 2002, Annu Rev Biochem). These phosphate groups are essential for maintaining the structural integrity of the bacterial outer membrane by forming ionic bridges with divalent cations like magnesium and calcium. In clinical medicine, these groups serve as the primary binding site for cationic polypeptide antibiotics, such as polymyxin B and colistin, which disrupt the membrane through electrostatic displacement of these cations (Velkov et al., 2010, J Med Chem). Beyond their structural role, the phosphate groups are critical for the recognition of LPS by the human TLR4/MD-2 receptor complex, which initiates the pro-inflammatory signaling cascade responsible for sepsis and septic shock (Park et al., 2009, Nature). Bacterial resistance often involves the enzymatic modification of these phosphate groups with moieties like phosphoethanolamine or 4-amino-4-deoxy-L-arabinose to reduce the overall negative charge and evade antibiotic binding (Liu et al., 2016, Lancet Infect Dis).
Cationic drugs bind electrostatically to the negatively charged phosphate groups on lipid A, displacing divalent cations (Ca2+ and Mg2+) that stabilize the outer membrane, leading to membrane disruption and cell lysis (Velkov et al., 2013, Future Med Chem).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid A phosphate groups (LPS-P).